These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Impact of histone deacetylase inhibitor valproic acid on the anticancer effect of etoposide on neuroblastoma cells. Groh T; Hrabeta J; Poljakova J; Eckschlager T; Stiborova M Neuro Endocrinol Lett; 2012; 33 Suppl 3():16-24. PubMed ID: 23353839 [TBL] [Abstract][Full Text] [Related]
3. The synergistic effects of DNA-damaging drugs cisplatin and etoposide with a histone deacetylase inhibitor valproate in high-risk neuroblastoma cells. Groh T; Hrabeta J; Khalil MA; Doktorova H; Eckschlager T; Stiborova M Int J Oncol; 2015 Jul; 47(1):343-52. PubMed ID: 25963435 [TBL] [Abstract][Full Text] [Related]
4. Sodium valproate potentiates staurosporine-induced apoptosis in neuroblastoma cells via Akt/survivin independently of HDAC inhibition. Shah RD; Jagtap JC; Mruthyunjaya S; Shelke GV; Pujari R; Das G; Shastry P J Cell Biochem; 2013 Apr; 114(4):854-63. PubMed ID: 23097134 [TBL] [Abstract][Full Text] [Related]
5. Downregulation of Nrf2 by the combination of TRAIL and Valproic acid induces apoptotic cell death of TRAIL-resistant papillary thyroid cancer cells via suppression of Bcl-xL. Cha HY; Lee BS; Chang JW; Park JK; Han JH; Kim YS; Shin YS; Byeon HK; Kim CH Cancer Lett; 2016 Mar; 372(1):65-74. PubMed ID: 26721202 [TBL] [Abstract][Full Text] [Related]
7. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207 [TBL] [Abstract][Full Text] [Related]
8. 2-Deoxyglucose treatment complements the cisplatin- or BH3-only mimetic-induced suppression of neuroblastoma cell growth. Chuang JH; Chou MH; Tai MH; Lin TK; Liou CW; Chen T; Hsu WM; Wang PW Int J Biochem Cell Biol; 2013 May; 45(5):944-51. PubMed ID: 23395630 [TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors VPA and TSA induce apoptosis and autophagy in pancreatic cancer cells. Gilardini Montani MS; Granato M; Santoni C; Del Porto P; Merendino N; D'Orazi G; Faggioni A; Cirone M Cell Oncol (Dordr); 2017 Apr; 40(2):167-180. PubMed ID: 28160167 [TBL] [Abstract][Full Text] [Related]
10. The Histone Deacetylase Inhibitor Valproic Acid Exerts a Synergistic Cytotoxicity with the DNA-Damaging Drug Ellipticine in Neuroblastoma Cells. Cerna T; Hrabeta J; Eckschlager T; Frei E; Schmeiser HH; Arlt VM; Stiborová M Int J Mol Sci; 2018 Jan; 19(1):. PubMed ID: 29304031 [TBL] [Abstract][Full Text] [Related]
11. Allicin Overcomes Hypoxia Mediated Cisplatin Resistance in Lung Cancer Cells through ROS Mediated Cell Death Pathway and by Suppressing Hypoxia Inducible Factors. Pandey N; Tyagi G; Kaur P; Pradhan S; Rajam MV; Srivastava T Cell Physiol Biochem; 2020 Aug; 54(4):748-766. PubMed ID: 32809300 [TBL] [Abstract][Full Text] [Related]
12. [Experimental study on the mechanism of the apoptosis of leukemic cells induced by valproic acid]. Xue HM; Li WY; Guo HX; Xia Y; Chen Q; Liu Y Zhonghua Er Ke Za Zhi; 2005 Dec; 43(12):894-8. PubMed ID: 16412349 [TBL] [Abstract][Full Text] [Related]
13. Valproic acid induces apoptosis in chronic lymphocytic leukemia cells through activation of the death receptor pathway and potentiates TRAIL response. Lagneaux L; Gillet N; Stamatopoulos B; Delforge A; Dejeneffe M; Massy M; Meuleman N; Kentos A; Martiat P; Willems L; Bron D Exp Hematol; 2007 Oct; 35(10):1527-37. PubMed ID: 17697742 [TBL] [Abstract][Full Text] [Related]
14. Valproate, in combination with pemetrexed and cisplatin, provides additional efficacy to the treatment of malignant mesothelioma. Vandermeers F; Hubert P; Delvenne P; Mascaux C; Grigoriu B; Burny A; Scherpereel A; Willems L Clin Cancer Res; 2009 Apr; 15(8):2818-28. PubMed ID: 19351772 [TBL] [Abstract][Full Text] [Related]
15. Prevention of hypoxia-induced neuronal apoptosis through histone deacetylase inhibition. Li Y; Yuan Z; Liu B; Sailhamer EA; Shults C; Velmahos GC; Demoya M; Alam HB J Trauma; 2008 Apr; 64(4):863-70; discussion 870-1. PubMed ID: 18404049 [TBL] [Abstract][Full Text] [Related]
16. Valproic acid inhibits proliferation of HER2-expressing breast cancer cells by inducing cell cycle arrest and apoptosis through Hsp70 acetylation. Mawatari T; Ninomiya I; Inokuchi M; Harada S; Hayashi H; Oyama K; Makino I; Nakagawara H; Miyashita T; Tajima H; Takamura H; Fushida S; Ohta T Int J Oncol; 2015 Dec; 47(6):2073-81. PubMed ID: 26497673 [TBL] [Abstract][Full Text] [Related]
17. Scriptaid overcomes hypoxia-induced cisplatin resistance in both wild-type and mutant p53 lung cancer cells. Pradhan S; Mahajan D; Kaur P; Pandey N; Sharma C; Srivastava T Oncotarget; 2016 Nov; 7(44):71841-71855. PubMed ID: 27708247 [TBL] [Abstract][Full Text] [Related]
18. Effect of histone deacetylase inhibitors trichostatin A and valproic acid on etoposide-induced apoptosis in leukemia cells. Jasek E; Lis GJ; Jasinska M; Jurkowska H; Litwin JA Anticancer Res; 2012 Jul; 32(7):2791-9. PubMed ID: 22753739 [TBL] [Abstract][Full Text] [Related]
19. Valproic acid, a histone deacetylase inhibitor, induces apoptosis in breast cancer stem cells. Aztopal N; Erkisa M; Erturk E; Ulukaya E; Tokullugil AH; Ari F Chem Biol Interact; 2018 Jan; 280():51-58. PubMed ID: 29225137 [TBL] [Abstract][Full Text] [Related]
20. Valproic acid inhibits adhesion of vincristine- and cisplatin-resistant neuroblastoma tumour cells to endothelium. Blaheta RA; Michaelis M; Natsheh I; Hasenberg C; Weich E; Relja B; Jonas D; Doerr HW; Cinatl J Br J Cancer; 2007 Jun; 96(11):1699-706. PubMed ID: 17505515 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]